Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors

Molecular Pharmacology

Volumn 74, Issue 2, 2008, Pages 423-431

  Stepanov, Alexander ^a   Nitiss, Karin C ^a   Neale, Geoffrey ^a   Nitiss, John L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETOPOSIDE; FUNGAL PROTEIN; GLYCOPROTEIN P; MICONAZOLE; PARACETAMOL; PDR5 PROTEIN; PLEIOTROPIC DRUG RESISTANCE 1; REPRESSOR PROTEIN; RHODAMINE;

ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DNA BINDING; DRUG ACCUMULATION; DRUG MECHANISM; DRUG SENSITIVITY; FUNGAL GENE; FUNGAL STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; YEAST; YEAST CELL;

ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, FUNGAL; GENES, FUNGAL; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 47949112518     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.044651     Document Type: Article

References (48)

1. Baetz K, McHardy L, Gable K, Tarling T, Reberioux D, Bryan J, Andersen RJ, Dunn T, Hieter P, and Roberge M (2004) Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc Natl Acad Sci U S A 101:4525-4530.
2. Balzi E, Chen W, Ulaszewski S, Capieaux E, and Goffeau A (1987) The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J Biol Chem 262:16871-16879.
3. Balzi E and Goffeau A (1991) Multiple or pleiotropic drug resistance in yeast. Biochim Biophys Acta 1073:241-252.
4. Balzi E, Wang M, Leterme S, Van Dyck L, and Goffeau A (1994) PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 269:2206-2214.
5. Benjamini Y and YH (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300.
6. Bennett CB, Lewis LK, Karthikeyan G, Lobachev KS, Jin YH, Sterling JF, Snipe JR, and Resnick MA (2001) Genes required for ionizing radiation resistance in yeast. Nat Genet 29:426-434.
7. Chang M, Bellaoui M, Boone C, and Brown GW (2002) A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc Natl Acad Sci USA 99:16934-16939.
8. 2+ levels in Chang liver cells. Toxicon 40:851-856.
9. Davie JK, Edmondson DG, Coco CB, and Dent SY (2003) Tup1-Ssn6 interacts with multiple class I histone deacetylases in vivo. J Biol Chem 278:50158-50162.
10. Deng C, Brown JA, You D, and Brown JM (2005) Multiple Endonucleases Function to Repair Covalent Topoisomerase I Complexes in Saccharomyces cerevisiae. Genetics 170:591-600.
11. DeRisi J, van den Hazel B, Marc P, Balzi E, Brown P, Jacq C, and Goffeau A (2000) Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett 470:156-160.
12. Dunstan HM, Ludlow C, Goehle S, Cronk M, Szankasi P, Evans DR, Simon JA, and Lamb JR (2002) Cell-based assays for identification of novel double-strand break-inducing agents. J Natl Cancer Inst 94:88-94.
13. Emter R, Heese-Peck A, and Kralli A (2002) ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms. FEBS Lett 521:57-61.
14. Ernst R, Klemm R, Schmitt L, and Kuchler K (2005) Yeast ATP-binding cassette transporters: cellular cleaning pumps. Methods Enzymol 400:460-484.
15. García-Sánchez S, Mavor AL, Russell CL, Argimon S, Dennison P, Enjalbert B, and Brown AJ (2005) Global roles of Ssn6 in Tup1- and Nrg1-dependent gene regulation in the fungal pathogen, Candida albicans. Mol Biol Cell 16:2913-2925.
16. Giaever G, Shoemaker DD, Jones TW, Liang H, Winzeler EA, Astromoff A, and Davis RW (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21:278-283.
17. Gietz D, St. Jean A, Woods RA, and Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425.
18. Golin J, Ambudkar SV, Gottesman MM, Habib AD, Sczepanski J, Ziccardi W, and May L (2003) Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem 278:5963-5969.
19. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
20. Hikkel I, Lucau-Danila A, Delaveau T, Marc P, Devaux F, and Jacq C (2003) A general strategy to uncover transcription factor properties identifies a new regulator of drug resistance in yeast. J Biol Chem 278:11427- 11432.
21. Huang RY, Eddy M, Vujcic M, and Kowalski D (2005) Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae. Cancer Res 65:5890-5897.
22. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, and O'Shea EK (2003) Global analysis of protein localization in budding yeast. Nature 425: 686-691.
23. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, and Lee JK (2003) Local-poolederror test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19:1945-1951.
24. Jungwirth H and Kuchler K (2006) Yeast ABC transporters - a tale of sex, stress, drugs and aging. FEBS Lett 580:1131-1138.
25. Kadosh D and Struhl K (1998) Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo. Mol Cell Biol 18:5121-5127.
26. Kasten MM, Dorland S, and Stillman DJ (1997) A large protein complex containing the yeast Sin3p and Rpd3p transcriptional regulators. Mol Cell Biol 17:4852-4858.
27. Katzmann DJ, Burnett PE, Golin J, Mahé Y, and Moye-Rowley WS (1994) Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol Cell Biol 14:4653-4661.
28. Katzmann DJ, Hallstrom TC, Mahé Y, and Moye-Rowley WS (1996) Multiple Pdr1p/ Pdr3p binding sites are essential for normal expression of the ATP binding cassette transporter protein-encoding gene PDR5. J Biol Chem 271:23049-23054.
29. Keleher CA, Redd MJ, Schultz J, Carlson M, and Johnson AD (1992) Ssn6-Tup1 is a general repressor of transcription in yeast. Cell 68:709-719.
30. Leonard PJ, Rathod PK, and Golin J (1994) Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux. Antimicrob Agents Chemother 38:2492-2494.
31. Mahé Y, Parle-McDermott A, Nourani A, Delahodde A, Lamprecht A, and Kuchler K (1996) The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol Microbiol 20:109-117.
32. Meyers S, Schauer W, Balzi E, Wagner M, Goffeau A, and Golin J (1992) Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr Genet 21: 431-436.
33. Mitterbauer R, Weindorfer H, Safaie N, Krska R, Lemmens M, Ruckenbauer P, Kuchler K, and Adam G (2003) A sensitive and inexpensive yeast bioassay for the mycotoxin zearalenone and other compounds with estrogenic activity. Appl Environ Microbiol 69:805-811.
34. Moye-Rowley WS (2003) Transcriptional control of multidrug resistance in the yeast Saccharomyces. Prog Nucleic Acid Res Mol Biol 73:251-279.
35. Nitiss J and Wang JC (1988) DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci U S A 85:7501-7505.
36. Nitiss JL and Heitman J (2007) Yeast As a Tool in Cancer Research. Springer, Dordrecht, The Netherlands.
37. Nitiss JL, Liu YX, Harbury P, Jannatipour M, Wasserman R, and Wang JC (1992) Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Res 52:4467-4472.
38. Nitiss KC, Malik M, He X, White SW, and Nitiss JL (2006) Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage. Proc Natl Acad Sci U S A 103:8953-8958.
39. Qiu J, Levin LR, Buck J, and Reidenberg MM (2002) Different pathways of cell killing by gossypol enantiomers. Exp Biol Med (Maywood) 227:398-401.
40. Sambrook J, Fritsch EF, and Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
41. Scherens B and Goffeau (2004) A The uses of genome-wide yeast mutant collections. Genome Biol 5:229.
42. Srikanth CV, Chakraborti AK, and Bachhawat AK (2005) Acetaminophen toxicity and resistance in the yeast Saccharomyces cerevisiae. Microbiology 151:99-111.
43. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H, et al. (2001) Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294:2364-2368.
44. van den Hazel HB, Pichler H, do Valle Matta MA, Leitner E, Goffeau A, and Daum G (1999) PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J Biol Chem 274:1934-1941.
45. Wang H and Stillman DJ (1993) Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol Cell Biol 13:1805-1814.
46. Westmoreland TJ, Marks JR, Olson JA Jr, Thompson EM, Resnick MA, and Bennett CB (2004) Cell cycle progression in G1 and S phases is CCR4 dependent following ionizing radiation or replication stress in Saccharomyces cerevisiae. Eukaryot Cell 3:430-446.
47. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285:901-906.
48. Zhang Z and Reese JC (2004) Ssn6-Tup1 requires the ISW2 complex to position nucleosomes in Saccharomyces cerevisiae. EMBO J 23:2246-2257.